Future mobility, here and now. FEV's autonomous driving.
FEV is participating in the EU-funded autonomous driving project (Hi-Drive) alongside 41 companies, including European OEMs and Tier 1 suppliers, focusing on evaluating data loggers for autonomous driving and developing V2V (Vehicle-to-Vehicle) communication technologies. They are working on solving challenges in complex traffic scenarios and aiming for the evolution of advanced autonomous driving technologies. They have implemented AD/ADAS software equivalent to Level 3+ and successfully merged onto highways.
Inquire About This Product
basic information
Unique AD/ADAS algorithms Position recognition using GPS and high-resolution maps Real-time data analysis
Price range
Delivery Time
Applications/Examples of results
Comprehensive support from concept to mass production. We provide a wide range of solutions that can address the entire mobility ecosystem.
Company information
<About us> FEV Japan, Inc. is a company that leverages advanced technology and extensive experience to drive innovation in the mobility and energy sectors. We closely align with our customers' needs and fully support challenging projects as partners in building a sustainable future together. <FEV's Global Network and Technical Expertise> Based in Germany, FEV develops cutting-edge technologies tailored to the needs of customers in various regions. With development centers around the world, we ensure product reliability through rigorous quality control and performance evaluation. Our team consists of excellent engineers with expertise in various fields, who continuously pursue the latest technological trends to provide innovative solutions. <Expansion of Business Areas> Starting in 2024, FEV Japan will also begin offering technical support services to the energy and aerospace industries. We will fully support our customers' challenges not only with the insights and experience gained from developing internal combustion engines but also with cutting-edge technology.
![[ChemOffice Case Study] Tokyo University of Pharmacy and Life Sciences](https://image.mono.ipros.com/public/product/image/341/2001491951/IPROS16547826039617343212.png?w=280&h=280)
